1. Home
  2. ATRC vs CASH Comparison

ATRC vs CASH Comparison

Compare ATRC & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • CASH
  • Stock Information
  • Founded
  • ATRC 2000
  • CASH 1954
  • Country
  • ATRC United States
  • CASH United States
  • Employees
  • ATRC N/A
  • CASH N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • CASH Major Banks
  • Sector
  • ATRC Health Care
  • CASH Finance
  • Exchange
  • ATRC Nasdaq
  • CASH Nasdaq
  • Market Cap
  • ATRC 1.6B
  • CASH 1.8B
  • IPO Year
  • ATRC 2005
  • CASH N/A
  • Fundamental
  • Price
  • ATRC $31.76
  • CASH $82.73
  • Analyst Decision
  • ATRC Strong Buy
  • CASH Buy
  • Analyst Count
  • ATRC 10
  • CASH 2
  • Target Price
  • ATRC $49.60
  • CASH $92.00
  • AVG Volume (30 Days)
  • ATRC 424.4K
  • CASH 192.5K
  • Earning Date
  • ATRC 07-29-2025
  • CASH 07-23-2025
  • Dividend Yield
  • ATRC N/A
  • CASH 0.24%
  • EPS Growth
  • ATRC N/A
  • CASH 10.71
  • EPS
  • ATRC N/A
  • CASH 7.36
  • Revenue
  • ATRC $480,076,000.00
  • CASH $731,383,000.00
  • Revenue This Year
  • ATRC $14.63
  • CASH $13.95
  • Revenue Next Year
  • ATRC $12.62
  • CASH $5.74
  • P/E Ratio
  • ATRC N/A
  • CASH $11.24
  • Revenue Growth
  • ATRC 15.79
  • CASH 6.51
  • 52 Week Low
  • ATRC $20.20
  • CASH $56.30
  • 52 Week High
  • ATRC $43.11
  • CASH $86.00
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 44.34
  • CASH 69.36
  • Support Level
  • ATRC $30.85
  • CASH $78.76
  • Resistance Level
  • ATRC $33.15
  • CASH $78.01
  • Average True Range (ATR)
  • ATRC 0.98
  • CASH 1.89
  • MACD
  • ATRC -0.10
  • CASH 0.96
  • Stochastic Oscillator
  • ATRC 36.52
  • CASH 95.65

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: